Xcout Intel
Seraxis Holdings, Inc.
Seraxis Holdings, Inc. is a private United States company that announced a merger in September 2026 to form a diabetes-focused biotech company.
Subscribe to see Seraxis Holdings, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Seraxis Holdings, Inc. at a glance
Seraxis Holdings, Inc. is a company headquartered in United States. It has raised at least $24M across the 2 funding rounds on record. Its most recent funding round raised $10M in September 2026. Xcout tracks 3 named people at Seraxis Holdings, Inc., including Carole Welsch (Executive Officer).
Seraxis Holdings, Inc. leadership
- Carole WelschExecutive Officer
- William L. RustExecutive Officer
- Jerry BatyDirector
Seraxis Holdings, Inc. funding rounds
At least $24M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10M | — | |
| SEC Form D filing | $14M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Seraxis Holdings, Inc. news
Seraxis Holdings, Inc. competitors
A few of Seraxis Holdings, Inc.'s closest competitors — see the full list of competitors and alternatives →
Semma Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing cell therapies for the treatment of diabetes.
Paulex Bio Inc. is a biotechnology company headquartered in San Diego, California, focused on transformative treatments for type 1 and type 2 diabetes. Its lead approach targets beta cell regeneration through an oral administration.
DiogenX is a preclinical-stage biotechnology company headquartered in Marseille, France, with research laboratories in Nice, dedicated to developing novel treatments for diabetes.
Metabolics Pharma, Inc. is a private pharmaceutical company based in Pennsylvania, United States, focusing on drug pipelines, patents, and clinical development for diabetes.
Get Seraxis Holdings, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Seraxis Holdings, Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access